Buy PeptidesCompendio di riferimento
Cerca

Info

Informazioni su questo riferimento

Che cos'è questo sito, che cosa non è e da dove viene ogni dato.

Che cos'è

Un elenco di consultazione sui peptidi: che cos'è ciascuno, la sua identità chimica e una selezione della ricerca pubblicata che lo riguarda. È pensato per leggere e per orientarsi.

Che cosa non è

  • Non è un negozio di peptidi: qui nessun peptide si vende o si può ordinare e non ci sono collegamenti a venditori. In vendita ci sono solo gli integratori alimentari e le vitamine del banco.
  • Non dice a nessuno come usare una sostanza. Non ci sono indicazioni su quantità, somministrazione o schemi d'uso.
  • Non è un consiglio medico.

Stato legale e medico

Alcune delle sostanze elencate sono medicinali soggetti a prescrizione. Altre non sono approvate come medicinali in nessun Paese e sono prodotte, se lo sono, per la ricerca di laboratorio. Che cosa si possa vendere, acquistare o detenere dipende dal Paese, e questo sito non prende posizione al riguardo. Per una questione di salute, rivolgiti a un medico o a un farmacista.

Da dove vengono i dati

  • PubChem (National Library of Medicine): formula, peso molecolare, nomi e rappresentazioni della struttura.
  • PubMed (National Library of Medicine): l'elenco dei lavori pubblicati.
  • Wikipedia: la frase di presentazione, disponibile con licenza CC BY-SA 4.0; le brevi descrizioni vengono da Wikidata (CC0).

Dati recuperati il 2026-10-08. I dati possono essere superati o sbagliati: controlla la fonte originale prima di farci affidamento.

Come è scelto l'elenco

L'elenco è redazionale, e lo sono anche i campi di ricerca sotto cui le voci sono raggruppate. Il fatto che una sostanza vi compaia non dice nulla sulla sua sicurezza, qualità o approvazione.

Le pagine di scienza

Le pagine sotto Scienza sono chimica generale scritta per questo sito. Descrivono come i peptidi si costruiscono e si misurano in generale, non una sostanza dell'elenco.

Lingue

Le pagine sono disponibili in più lingue. I titoli degli articoli sono riportati come pubblicati, di solito in inglese. Dove Wikipedia non ha una voce in una lingua, viene mostrata la frase in inglese, con un avviso.

Le basi

Dall'alfabeto degli amminoacidi all'analisi

I peptidi sono brevi catene di amminoacidi. Queste quattro introduzioni spiegano di che cosa sono fatti, che cosa tiene insieme la catena, come si producono e come si controllano. Chimica generale, scritta per orientarsi.

01

Amminoacidi

Ogni peptide è una catena di amminoacidi. Venti sono codificati direttamente dal codice genetico, e il loro ordine nella catena decide che cosa è la molecola.

Leggi →02

Il legame peptidico

Un legame peptidico è il legame ammidico tra un amminoacido e il successivo. La sua geometria è il motivo per cui i peptidi hanno una forma, non solo una sequenza.

Leggi →03

Sintesi

La maggior parte dei peptidi per la ricerca e per i farmaci si costruisce chimicamente, un amminoacido alla volta, su un supporto solido. Quelli più grandi sono spesso prodotti da cellule viventi.

Leggi →04

Analisi

Un flaconcino di polvere bianca non dice nulla su ciò che contiene. Identità, purezza e contenuto sono domande distinte, e a ciascuna risponde una misura diversa.

Leggi →

Studi pubblicati

La letteratura, voce per voce

Tutti gli articoli elencati in questo sito, raggruppati per peptide. I titoli sono riportati come pubblicati. Elencare un articolo non significa avallarne le conclusioni, e molti di questi sono studi di laboratorio o su animali.

Tipi di studio tra gli articoli elencati, come registrati da PubMed:

  • Review · 153
  • Research Support, Non-U.S. Gov't · 102
  • Randomized Controlled Trial · 25
  • Research Support, N.I.H., Extramural · 19
  • Multicenter Study · 15
  • Systematic Review · 15
  • Clinical Trial, Phase III · 13
  • Comparative Study · 11
  • Clinical Trial, Phase II · 6
  • Editorial · 6
  • Network Meta-Analysis · 6
  • Research Support, U.S. Gov't, Non-P.H.S. · 5
  • Equivalence Trial · 3
  • Research Support, U.S. Gov't, P.H.S. · 3
  • Validation Study · 3
  • Case Reports · 2
  • Meta-Analysis · 2
  • Observational Study · 2
  • Bibliography · 1
  • Comment · 1
  • English Abstract · 1
  • Evaluation Study · 1
  • Introductory Journal Article · 1
  • News · 1
  • Newspaper Article · 1
  • Published Erratum · 1
  • Research Support, N.I.H., Intramural · 1
  • Retracted Publication · 1
  • Study Guide · 1

Acetyl hexapeptide-8

  1. Cosmeceuticals in photoaging: A reviewSystematic ReviewChan LKW, Lee KWA, Lee CH et al. · Skin Res Technol, 2024 · PMID 39233460 · DOI
  2. Acetyl Hexapeptide-8 in Cosmeceuticals-A Review of Skin Permeability and EfficacyReviewZdrada-Nowak J, Surgiel-Gemza A, Szatkowska M · Int J Mol Sci, 2025 · PMID 40565185 · DOI
  3. A synthetic hexapeptide (Argireline) with antiwrinkle activityBlanes-Mira C, Clemente J, Jodas G et al. · Int J Cosmet Sci, 2002 · PMID 18498523 · DOI
  4. The anti-wrinkle efficacy of ArgirelineWang Y, Wang M, Xiao XS et al. · J Cosmet Laser Ther, 2013 · PMID 23464592 · DOI
  5. Public Interest in Acetyl Hexapeptide-8: Longitudinal AnalysisOlsson SE, Sreepad B, Lee T et al. · JMIR Dermatol, 2024 · PMID 38376906 · DOI
  6. The study of cellular cytotoxicity of argireline - an anti-aging peptideResearch Support, Non-U.S. Gov'tGrosicki M, Latacz G, Szopa A et al. · Acta Biochim Pol, 2014 · PMID 24644551
  7. Argireline: Needle-Free Botox as Analytical ChallengeKluczyk A, Ludwiczak J, Modzel M et al. · Chem Biodivers, 2021 · PMID 33482052 · DOI
  8. The anti wrinkle efficacy of synthetic hexapeptide (Argireline) in Chinese SubjectsWang Y, Wang M, Xiao XS et al. · J Cosmet Laser Ther, 2013 · PMID 23607739 · DOI

I primi 8 di 47 risultati, per pertinenza. Vedi tutti su PubMed.

Afamelanotide

  1. Vitiligo: Pathogenesis and New and Emerging TreatmentsReviewPerez-Bootello J, Cova-Martin R, Naharro-Rodriguez J et al. · Int J Mol Sci, 2023 · PMID 38139134 · DOI
  2. AfamelanotideReview2012 · PMID 38598652
  3. From pathogenesis of acne vulgaris to anti-acne agentsReviewCong TX, Hao D, Wen X et al. · Arch Dermatol Res, 2019 · PMID 30859308 · DOI
  4. An overview of the cutaneous porphyriasReviewDawe R · F1000Res, 2017 · PMID 29152226 · DOI
  5. Treatment Advances in Vitiligo: An Updated ReviewReviewIsmail IB, Bhat YJ, Ul Islam MS · Dermatol Pract Concept, 2025 · PMID 40117616 · DOI
  6. Phototherapy for VitiligoReviewZubair R, Hamzavi IH · Dermatol Clin, 2020 · PMID 31753192 · DOI
  7. X-Linked ProtoporphyriaReviewAdam MP, Bick S, Mirzaa GM et al. · 1993 · PMID 23409301
  8. Afamelanotide: A Review in Erythropoietic ProtoporphyriaReviewKim ES, Garnock-Jones KP · Am J Clin Dermatol, 2016 · PMID 26979527 · DOI

I primi 8 di 104 risultati, per pertinenza. Vedi tutti su PubMed.

AOD-9604

  1. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsReviewRahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev, 2026 · PMID 41490200 · DOI
  2. AOD-9604 MetabolicReviewWilding J · Curr Opin Investig Drugs, 2004 · PMID 15134286
  3. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceReviewMendias CL, Awan TM · Sports Med, 2026 · PMID 41966639 · DOI
  4. Detection and in vitro metabolism of AOD9604Research Support, N.I.H., ExtramuralValidation StudyCox HD, Smeal SJ, Hughes CM et al. · Drug Test Anal, 2015 · PMID 25208511 · DOI
  5. Effect of Intra-articular Injection of AOD9604 with or without Hyaluronic Acid in Rabbit Osteoarthritis ModelKwon DR, Park GY · Ann Clin Lab Sci, 2015 · PMID 26275694
  6. Increase of fat oxidation and weight loss in obese mice caused by chronic treatment with human growth hormone or a modified C-terminal fragmentComparative StudyResearch Support, Non-U.S. Gov'tHeffernan MA, Thorburn AW, Fam B et al. · Int J Obes Relat Metab Disord, 2001 · PMID 11673763 · DOI
  7. The effects of human GH and its lipolytic fragment (AOD9604) on lipid metabolism following chronic treatment in obese mice and beta(3)-AR knock-out miceResearch Support, Non-U.S. Gov'tHeffernan M, Summers RJ, Thorburn A et al. · Endocrinology, 2001 · PMID 11713213 · DOI
  8. Metabolic studies of a synthetic lipolytic domain (AOD9604) of human growth hormoneNg FM, Sun J, Sharma L et al. · Horm Res, 2000 · PMID 11146367 · DOI

I primi 8 di 22 risultati, per pertinenza. Vedi tutti su PubMed.

BPC-157

  1. Multifunctionality and Possible Medical Application of the BPC 157 Peptide-Literature and Patent ReviewReviewJózwiak M, Bauer M, Kamysz W et al. · Pharmaceuticals (Basel), 2025 · PMID 40005999 · DOI
  2. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healingReviewGwyer D, Wragg NM, Wilson SL · Cell Tissue Res, 2019 · PMID 30915550 · DOI
  3. Stable Gastric Pentadecapeptide BPC 157 and Wound HealingReviewSeiwerth S, Milavic M, Vukojevic J et al. · Front Pharmacol, 2021 · PMID 34267654 · DOI
  4. Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic ReviewReviewVasireddi N, Hahamyan H, Salata MJ et al. · HSS J, 2025 · PMID 40756949 · DOI
  5. Fistulas Healing. Stable Gastric Pentadecapeptide BPC 157 TherapyResearch Support, Non-U.S. Gov'tReviewSikiric P, Drmic D, Sever M et al. · Curr Pharm Des, 2020 · PMID 32329684 · DOI
  6. BPC 157 and blood vesselsReviewSeiwerth S, Brcic L, Vuletic LB et al. · Curr Pharm Des, 2014 · PMID 23782145 · DOI
  7. Intra-Articular Injection of BPC 157 for Multiple Types of Knee PainLee E, Padgett B · Altern Ther Health Med, 2021 · PMID 34324435
  8. Effect of BPC-157 on Symptoms in Patients with Interstitial Cystitis: A Pilot StudyLee E, Walker C, Ayadi B · Altern Ther Health Med, 2024 · PMID 39325560

I primi 8 di 220 risultati, per pertinenza. Vedi tutti su PubMed.

Bremelanotide

  1. BremelanotideReview2012 · PMID 34436837
  2. BremelanotideReview2006 · PMID 31369224
  3. Hypoactive Sexual Desire Disorder in Women: Physiology, Assessment, Diagnosis, and TreatmentReviewPettigrew JA, Novick AM · J Midwifery Womens Health, 2021 · PMID 34510696 · DOI
  4. Bremelanotide: First ApprovalReviewDhillon S, Keam SJ · Drugs, 2019 · PMID 31429064 · DOI
  5. Therapeutic peptides in gerontology: mechanisms and applications for healthy agingReviewMavrych V, Shypilova I, Bolgova O · Front Aging, 2026 · PMID 42021992 · DOI
  6. Safety Profile of Bremelanotide Across the Clinical Development ProgramClinical Trial, Phase IIIRandomized Controlled TrialResearch Support, Non-U.S. Gov'tClayton AH, Kingsberg SA, Portman D et al. · J Womens Health (Larchmt), 2022 · PMID 35147466 · DOI
  7. Female Sexual Desire, Arousal, and Orgasmic Dysfunctions: A Systematic Review and Meta-Analysis of Treatment OptionsSystematic ReviewMeta-AnalysisToledo RG, Winkelman WD, Reyes-Gonzalez D et al. · J Minim Invasive Gynecol, 2026 · PMID 40543759 · DOI
  8. Targeting the central melanocortin system for the treatment of metabolic disordersReviewResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tSweeney P, Gimenez LE, Hernandez CC et al. · Nat Rev Endocrinol, 2023 · PMID 37365323 · DOI

I primi 8 di 94 risultati, per pertinenza. Vedi tutti su PubMed.

Cagrilintide

  1. Coadministered Cagrilintide and Semaglutide in Adults with Overweight or ObesityRandomized Controlled TrialMulticenter StudyClinical Trial, Phase IIIGarvey WT, Blüher M, Osorto Contreras CK et al. · N Engl J Med, 2025 · PMID 40544433 · DOI
  2. Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysisSystematic ReviewNetwork Meta-AnalysisYao H, Zhang A, Li D et al. · BMJ, 2024 · PMID 38286487 · DOI
  3. Cagrilintide-Semaglutide in Adults with Overweight or Obesity and Type 2 DiabetesRandomized Controlled TrialClinical Trial, Phase IIIMulticenter StudyDavies MJ, Bajaj HS, Broholm C et al. · N Engl J Med, 2025 · PMID 40544432 · DOI
  4. Weight management treatment in obesityReviewRubio-Herrera MA, Mera-Carreiro S · Med Clin (Barc), 2025 · PMID 40865172 · DOI
  5. Beyond weight loss: multisystem benefits of obesity medicationsReviewSavas M, Kuckuck S, Boon MR et al. · Lancet Diabetes Endocrinol, 2026 · PMID 42208956 · DOI
  6. Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trialClinical Trial, Phase IIMulticenter StudyRandomized Controlled TrialLau DCW, Erichsen L, Francisco AM et al. · Lancet, 2021 · PMID 34798060 · DOI
  7. Novel GLP-1-based Medications for Type 2 Diabetes and ObesityReviewSon JW, le Roux CW, Blüher M et al. · Endocr Rev, 2026 · PMID 41054801 · DOI
  8. Efficacy and safety of co-administered once-weekly cagrilintide 2·4 mg with once-weekly semaglutide 2·4 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trialRandomized Controlled TrialMulticenter StudyClinical Trial, Phase IIResearch Support, Non-U.S. Gov'tFrias JP, Deenadayalan S, Erichsen L et al. · Lancet, 2023 · PMID 37364590 · DOI

I primi 8 di 102 risultati, per pertinenza. Vedi tutti su PubMed.

Carnosine

  1. Carnosine and bone (Review)ReviewYang H, Hou X, Xing L et al. · Mol Med Rep, 2023 · PMID 36416346 · DOI
  2. Exercise alleviates hematopoietic stem cell injury following radiation via the carnosine/Slc15a2-p53 axisResearch Support, Non-U.S. Gov'tZeng H, Chen N, Chen F et al. · Cell Commun Signal, 2024 · PMID 39627813 · DOI
  3. Carnosine and Diabetic NephropathyReviewPeters V, Yard B, Schmitt CP · Curr Med Chem, 2020 · PMID 30914013 · DOI
  4. Carnosine in health and diseaseReviewArtioli GG, Sale C, Jones RL · Eur J Sport Sci, 2019 · PMID 29502490 · DOI
  5. Zinc, Carnosine, and Neurodegenerative DiseasesReviewKawahara M, Tanaka KI, Kato-Negishi M · Nutrients, 2018 · PMID 29382141 · DOI
  6. Anti-ischemic activity of carnosineReviewStvolinsky SL, Dobrota D · Biochemistry (Mosc), 2000 · PMID 10951104
  7. Carnosine and the processes of ageingReviewHipkiss AR, Baye E, de Courten B · Maturitas, 2016 · PMID 27344459 · DOI
  8. [Carnosine, carnosinase and kidney diseases]ReviewKiliś-Pstrusińska K · Postepy Hig Med Dosw (Online), 2012 · PMID 22706107 · DOI

I primi 8 di 3.213 risultati, per pertinenza. Vedi tutti su PubMed.

CJC-1295

  1. Prolonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adultsRandomized Controlled TrialResearch Support, Non-U.S. Gov'tTeichman SL, Neale A, Lawrence B et al. · J Clin Endocrinol Metab, 2006 · PMID 16352683 · DOI
  2. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine PhysiciansReviewMayfield CK, Bolia IK, Feingold CL et al. · Am J Sports Med, 2026 · PMID 41476424 · DOI
  3. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsReviewRahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev, 2026 · PMID 41490200 · DOI
  4. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceReviewMendias CL, Awan TM · Sports Med, 2026 · PMID 41966639 · DOI
  5. Peptide Supplements and Their Therapeutic Applications in Sports MedicineTewari K, Liu TP, Im C et al. · Am J Sports Med, 2026 · PMID 42578445 · DOI
  6. Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future PerspectivesReviewRenke G, Chinellato L · Int J Mol Sci, 2026 · PMID 42123471 · DOI
  7. Therapeutic peptides in gerontology: mechanisms and applications for healthy agingReviewMavrych V, Shypilova I, Bolgova O · Front Aging, 2026 · PMID 42021992 · DOI
  8. A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical reviewReviewCoutinho LFD, DE Oliveira Neves LF, Camilo RP · J Sports Med Phys Fitness, 2026 · PMID 41880199 · DOI

I primi 8 di 33 risultati, per pertinenza. Vedi tutti su PubMed.

Dihexa

  1. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsReviewRahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev, 2026 · PMID 41490200 · DOI
  2. Hepatocyte growth factor mimetic protects lateral line hair cells from aminoglycoside exposureUribe PM, Kawas LH, Harding JW et al. · Front Cell Neurosci, 2015 · PMID 25674052 · DOI
  3. The procognitive and synaptogenic effects of angiotensin IV-derived peptides are dependent on activation of the hepatocyte growth factor/c-met systemResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tRetracted PublicationBenoist CC, Kawas LH, Zhu M et al. · J Pharmacol Exp Ther, 2014 · PMID 25187433 · DOI
  4. AngIV-Analog Dihexa Rescues Cognitive Impairment and Recovers Memory in the APP/PS1 Mouse via the PI3K/AKT Signaling PathwaySun X, Deng Y, Fu X et al. · Brain Sci, 2021 · PMID 34827486 · DOI
  5. The Brain Hepatocyte Growth Factor/c-Met Receptor System: A New Target for the Treatment of Alzheimer's DiseaseResearch Support, Non-U.S. Gov'tReviewWright JW, Harding JW · J Alzheimers Dis, 2015 · PMID 25649658 · DOI
  6. Dimeric DOTA-alpha-melanocyte-stimulating hormone analogs: synthesis and in vivo characteristics of radiopeptides with high in vitro activityResearch Support, Non-U.S. Gov'tBapst JP, Froidevaux S, Calame M et al. · J Recept Signal Transduct Res, 2007 · PMID 18097939 · DOI
  7. Evaluation of metabolically stabilized angiotensin IV analogs as procognitive/antidementia agentsResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tMcCoy AT, Benoist CC, Wright JW et al. · J Pharmacol Exp Ther, 2013 · PMID 23055539 · DOI
  8. Stem cell, Granulocyte-Colony Stimulating Factor and/or Dihexa to promote limb function recovery in a rat sciatic nerve damage-repair model: Experimental animal studiesWeiss JB, Phillips CJ, Malin EW et al. · Ann Med Surg (Lond), 2021 · PMID 34703584 · DOI

I primi 8 di 18 risultati, per pertinenza. Vedi tutti su PubMed.

DSIP

  1. Delta sleep-inducing peptideEditorialReviewPollard BJ, Pomfrett CJ · Eur J Anaesthesiol, 2001 · PMID 11437870 · DOI
  2. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsReviewRahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev, 2026 · PMID 41490200 · DOI
  3. Delta-sleep-inducing peptide (DSIP): a reviewReviewGraf MV, Kastin AJ · Neurosci Biobehav Rev, 1984 · PMID 6145137 · DOI
  4. Delta-sleep-inducing peptide (DSIP): an updateResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, Non-P.H.S.ReviewGraf MV, Kastin AJ · Peptides, 1986 · PMID 3550726 · DOI
  5. Delta sleep-inducing peptide (DSIP): a still unresolved riddleResearch Support, Non-U.S. Gov'tReviewKovalzon VM, Strekalova TV · J Neurochem, 2006 · PMID 16539679 · DOI
  6. The delta EEG (sleep)-inducing peptide (DSIP). XI. Amino-acid analysis, sequence, synthesis and activity of the nonapeptideSchoenenberger GA, Maier PF, Tobler HJ et al. · Pflugers Arch, 1978 · PMID 568769 · DOI
  7. Delta sleep-inducing peptide (DSIP) stimulates LH release in steroid-primed ovariectomized ratsResearch Support, U.S. Gov't, P.H.S.Sahu A, Kalra SP · Life Sci, 1987 · PMID 3550343 · DOI
  8. Biochemical regulation of non-rapid-eye-movement sleepResearch Support, Non-U.S. Gov'tResearch Support, U.S. Gov't, P.H.S.ReviewObal F Jr, Krueger JM · Front Biosci, 2003 · PMID 12700031 · DOI

I primi 8 di 462 risultati, per pertinenza. Vedi tutti su PubMed.

Elamipretide

  1. Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical TrialRandomized Controlled TrialClinical Trial, Phase IIIResearch Support, Non-U.S. Gov'tKaraa A, Bertini E, Carelli V et al. · Neurology, 2023 · PMID 37268435 · DOI
  2. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceReviewMendias CL, Awan TM · Sports Med, 2026 · PMID 41966639 · DOI
  3. Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic PotentialReviewTung C, Varzideh F, Farroni E et al. · Int J Mol Sci, 2025 · PMID 39940712 · DOI
  4. Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in miceZhao W, Xu Z, Cao J et al. · J Neuroinflammation, 2019 · PMID 31747905 · DOI
  5. Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)ReviewNashine S · Cells, 2021 · PMID 34572131 · DOI
  6. Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future PerspectivesReviewRenke G, Chinellato L · Int J Mol Sci, 2026 · PMID 42123471 · DOI
  7. Elamipretide: First ApprovalReviewShirley M · Drugs, 2026 · PMID 41335372 · DOI
  8. Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trialRandomized Controlled TrialClinical Trial, Phase IIIResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tKaraa A, Bertini E, Carelli V et al. · Orphanet J Rare Dis, 2024 · PMID 39574155 · DOI

I primi 8 di 206 risultati, per pertinenza. Vedi tutti su PubMed.

Epitalon

  1. Overview of Epitalon-Highly Bioactive Pineal Tetrapeptide with Promising PropertiesReviewAraj SK, Brzezik J, Mądra-Gackowska K et al. · Int J Mol Sci, 2025 · PMID 40141333 · DOI
  2. Peptides and AgeingReviewKhavinson VKh · Neuro Endocrinol Lett, 2002 · PMID 12374906
  3. Therapeutic peptides in gerontology: mechanisms and applications for healthy agingReviewMavrych V, Shypilova I, Bolgova O · Front Aging, 2026 · PMID 42021992 · DOI
  4. Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activityResearch Support, Non-U.S. Gov'tAl-Dulaimi S, Thomas R, Matta S et al. · Biogerontology, 2025 · PMID 40908429 · DOI
  5. The Antioxidant Tetrapeptide Epitalon Enhances Delayed Wound Healing in an in Vitro Model of Diabetic RetinopathyResearch Support, Non-U.S. Gov'tGatta M, Dovizio M, Milillo C et al. · Stem Cell Rev Rep, 2025 · PMID 40493162 · DOI
  6. Epitalon protects against post-ovulatory aging-related damage of mouse oocytes in vitroResearch Support, Non-U.S. Gov'tYue X, Liu SL, Guo JN et al. · Aging (Albany NY), 2022 · PMID 35413689 · DOI
  7. Effect of the synthetic pineal peptide epitalon on spontaneous carcinogenesis in female C3H/He miceResearch Support, Non-U.S. Gov'tKossoy G, Anisimov VN, Ben-Hur H et al. · In Vivo, 2006 · PMID 16634527
  8. Epitalon influences pineal secretion in stress-exposed rats in the daytimeSibarov DA, Kovalenko RI, Malinin VV et al. · Neuro Endocrinol Lett, 2002 · PMID 12500171

I primi 8 di 63 risultati, per pertinenza. Vedi tutti su PubMed.

GHK-Cu

  1. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene DataReviewPickart L, Margolina A · Int J Mol Sci, 2018 · PMID 29986520 · DOI
  2. The potential of GHK as an anti-aging peptideDou Y, Lee A, Zhu L et al. · Aging Pathobiol Ther, 2020 · PMID 35083444 · DOI
  3. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine PhysiciansReviewMayfield CK, Bolia IK, Feingold CL et al. · Am J Sports Med, 2026 · PMID 41476424 · DOI
  4. Topically applied GHK as an anti-wrinkle peptide: Advantages, problems and prospectiveReviewMortazavi SM, Mohammadi Vadoud SA, Moghimi HR · Bioimpacts, 2025 · PMID 39963574 · DOI
  5. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsReviewRahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev, 2026 · PMID 41490200 · DOI
  6. Are We Ready to Measure Skin Permeation of Modern Antiaging GHK-Cu Tripeptide Encapsulated in Liposomes?ReviewOgórek K, Nowak K, Wadych E et al. · Molecules, 2025 · PMID 39795193 · DOI
  7. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceReviewMendias CL, Awan TM · Sports Med, 2026 · PMID 41966639 · DOI
  8. Peptide Supplements and Their Therapeutic Applications in Sports MedicineTewari K, Liu TP, Im C et al. · Am J Sports Med, 2026 · PMID 42578445 · DOI

I primi 8 di 82 risultati, per pertinenza. Vedi tutti su PubMed.

GHRP-2

  1. Ipamorelin, the first selective growth hormone secretagogueRaun K, Hansen BS, Johansen NL et al. · Eur J Endocrinol, 1998 · PMID 9849822 · DOI
  2. Pralmorelin: GHRP 2, GPA 748, growth hormone-releasing peptide 2, KP-102 D, KP-102 LN, KP-102D, KP-102LNReviewDrugs R D, 2004 · PMID 15230633 · DOI
  3. Growth hormone-releasing peptidesResearch Support, Non-U.S. Gov'tReviewGhigo E, Arvat E, Muccioli G et al. · Eur J Endocrinol, 1997 · PMID 9186261 · DOI
  4. Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometryEvaluation StudyResearch Support, Non-U.S. Gov'tOkano M, Sato M, Ikekita A et al. · Rapid Commun Mass Spectrom, 2010 · PMID 20552695 · DOI
  5. Pharmacological characteristics of KP-102 (GHRP-2), a potent growth hormone-releasing peptideDoi N, Hirotani C, Ukai K et al. · Arzneimittelforschung, 2004 · PMID 15646370 · DOI
  6. Gateways to clinical trialsReviewBayes M, Rabasseda X, Prous JR · Methods Find Exp Clin Pharmacol, 2002 · PMID 12092009
  7. Physiologically based pharmacokinetic model for pralmorelin hydrochloride in ratsNasu R, Kumagai Y, Kogetsu H et al. · Drug Metab Dispos, 2005 · PMID 16033952 · DOI
  8. Adult growth hormone deficiency: current conceptsResearch Support, Non-U.S. Gov'tReviewFukuda I, Hizuka N, Muraoka T et al. · Neurol Med Chir (Tokyo), 2014 · PMID 25070016 · DOI

I primi 8 di 212 risultati, per pertinenza. Vedi tutti su PubMed.

GHRP-6

  1. N-aminoimidazolidin-2-one peptidomimeticsResearch Support, Non-U.S. Gov'tDoan ND, Hopewell R, Lubell WD · Org Lett, 2014 · PMID 24697286 · DOI
  2. Growth hormone-releasing peptide 6 (GHRP-6) hydrogel for acute kidney injury therapy via metabolic regulationZhao X, Pan K, Li R et al. · J Nanobiotechnology, 2025 · PMID 41327290 · DOI
  3. Growth hormone releasing hexapeptide-6 (GHRP-6) test in the diagnosis of GH-deficiencyReviewPombo M, Leal-Cerro A, Barreiro J et al. · J Pediatr Endocrinol Metab, 1996 · PMID 8887178
  4. Calorie restriction activates a gastric Notch-FOXO1 pathway to expand ghrelin cellsResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tMcKimpson WM, Spiegel S, Mukhanova M et al. · J Cell Biol, 2024 · PMID 38958606 · DOI
  5. [D-Lys3]-GHRP-6 exhibits pro-autophagic effects on skeletal muscleResearch Support, Non-U.S. Gov'tYu AP, Pei XM, Sin TK et al. · Mol Cell Endocrinol, 2015 · PMID 25450862 · DOI
  6. Growth hormone releasing peptide-6 (GHRP-6) prevents doxorubicin-induced myocardial and extra-myocardial damages by activating prosurvival mechanismsBerlanga-Acosta J, Cibrian D, Valiente-Mustelier J et al. · Front Pharmacol, 2024 · PMID 38873418 · DOI
  7. Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and IpamorelinResearch Support, Non-U.S. Gov'tValidation StudySemenistaya E, Zvereva I, Thomas A et al. · Drug Test Anal, 2015 · PMID 25869809 · DOI
  8. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal malesReviewSinha DK, Balasubramanian A, Tatem AJ et al. · Transl Androl Urol, 2020 · PMID 32257855 · DOI

I primi 8 di 638 risultati, per pertinenza. Vedi tutti su PubMed.

Glutathione

  1. The antioxidant glutathioneResearch Support, Non-U.S. Gov'tAverill-Bates DA · Vitam Horm, 2023 · PMID 36707132 · DOI
  2. Glutathione as a skin-lightening agent and in melasma: a systematic reviewSystematic ReviewSarkar R, Yadav V, Yadav T et al. · Int J Dermatol, 2025 · PMID 39444151 · DOI
  3. GlutathioneNoctor G, Queval G, Mhamdi A et al. · Arabidopsis Book, 2011 · PMID 22303267 · DOI
  4. Glutathione and peroxisome redox homeostasisReviewResearch Support, Non-U.S. Gov'tFerreira MJ, Rodrigues TA, Pedrosa AG et al. · Redox Biol, 2023 · PMID 37804696 · DOI
  5. The Glutathione Theory of AgingReviewPelton R · Altern Ther Health Med, 2024 · PMID 39316535
  6. Mitochondrial Glutathione: Regulation and FunctionsReviewCalabrese G, Morgan B, Riemer J · Antioxid Redox Signal, 2017 · PMID 28558477 · DOI
  7. Glutathione in Brain Disorders and AgingReviewIskusnykh IY, Zakharova AA, Pathak D · Molecules, 2022 · PMID 35011559 · DOI
  8. Glutathione-Related Enzymes and Proteins: A ReviewReviewVašková J, Kočan L, Vaško L et al. · Molecules, 2023 · PMID 36771108 · DOI

I primi 8 di 179.730 risultati, per pertinenza. Vedi tutti su PubMed.

Hexarelin

  1. We are ageingReviewKolovou GD, Kolovou V, Mavrogeni S · Biomed Res Int, 2014 · PMID 25045704 · DOI
  2. Hexarelin treatment preserves myocardial function and reduces cardiac fibrosis in a mouse model of acute myocardial infarctionResearch Support, Non-U.S. Gov'tMcDonald H, Peart J, Kurniawan N et al. · Physiol Rep, 2018 · PMID 29756411 · DOI
  3. Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated ProteinMeanti R, Licata M, Rizzi L et al. · Int J Mol Sci, 2023 · PMID 36674509 · DOI
  4. Growth hormone-releasing peptidesResearch Support, Non-U.S. Gov'tReviewGhigo E, Arvat E, Muccioli G et al. · Eur J Endocrinol, 1997 · PMID 9186261 · DOI
  5. The cardiovascular action of hexarelinReviewMao Y, Tokudome T, Kishimoto I · J Geriatr Cardiol, 2014 · PMID 25278975 · DOI
  6. The Safety and Efficacy of Growth Hormone SecretagoguesResearch Support, N.I.H., ExtramuralReviewSigalos JT, Pastuszak AW · Sex Med Rev, 2018 · PMID 28400207 · DOI
  7. The CD36-PPARγ Pathway in Metabolic DisordersReviewMaréchal L, Laviolette M, Rodrigue-Way A et al. · Int J Mol Sci, 2018 · PMID 29883404 · DOI
  8. Growth hormone in obesityReviewScacchi M, Pincelli AI, Cavagnini F · Int J Obes Relat Metab Disord, 1999 · PMID 10193871 · DOI

I primi 8 di 291 risultati, per pertinenza. Vedi tutti su PubMed.

Humanin

  1. Mitochondrial stress and mitokines in agingReviewResearch Support, Non-U.S. Gov'tBurtscher J, Soltany A, Visavadiya NP et al. · Aging Cell, 2023 · PMID 36642986 · DOI
  2. Neuron-derived extracellular vesicles in blood reveal effects of exercise in Alzheimer's diseaseRandomized Controlled TrialResearch Support, N.I.H., IntramuralResearch Support, Non-U.S. Gov'tDelgado-Peraza F, Nogueras-Ortiz C, Simonsen AH et al. · Alzheimers Res Ther, 2023 · PMID 37730689 · DOI
  3. Myeloid cells coordinately induce glioma cell-intrinsic and cell-extrinsic pathways for chemoresistance via GP130 signalingResearch Support, Non-U.S. Gov'tCheng J, Li M, Motta E et al. · Cell Rep Med, 2024 · PMID 39053460 · DOI
  4. Humanin: Functional Interfaces with IGF-IReviewResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tXiao J, Kim SJ, Cohen P et al. · Growth Horm IGF Res, 2016 · PMID 27082450 · DOI
  5. Mitochondria-derived peptide SHLP2 regulates energy homeostasis through the activation of hypothalamic neuronsResearch Support, Non-U.S. Gov'tKim SK, Tran LT, NamKoong C et al. · Nat Commun, 2023 · PMID 37468558 · DOI
  6. Humanin and the receptors for humaninResearch Support, Non-U.S. Gov'tReviewMatsuoka M, Hashimoto Y · Mol Neurobiol, 2010 · PMID 19997871 · DOI
  7. Mitochondrial-Derived Peptides Exacerbate SenescenceReviewMendelsohn AR, Larrick JW · Rejuvenation Res, 2018 · PMID 30058454 · DOI
  8. The role of humanin in the regulation of reproductionResearch Support, Non-U.S. Gov'tReviewLei H, Rao M · Biochim Biophys Acta Gen Subj, 2022 · PMID 34626748 · DOI

I primi 8 di 547 risultati, per pertinenza. Vedi tutti su PubMed.

Ipamorelin

  1. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine PhysiciansReviewMayfield CK, Bolia IK, Feingold CL et al. · Am J Sports Med, 2026 · PMID 41476424 · DOI
  2. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsReviewRahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev, 2026 · PMID 41490200 · DOI
  3. Ipamorelin, the first selective growth hormone secretagogueRaun K, Hansen BS, Johansen NL et al. · Eur J Endocrinol, 1998 · PMID 9849822 · DOI
  4. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceReviewMendias CL, Awan TM · Sports Med, 2026 · PMID 41966639 · DOI
  5. Peptide Supplements and Their Therapeutic Applications in Sports MedicineTewari K, Liu TP, Im C et al. · Am J Sports Med, 2026 · PMID 42578445 · DOI
  6. Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future PerspectivesReviewRenke G, Chinellato L · Int J Mol Sci, 2026 · PMID 42123471 · DOI
  7. Therapeutic peptides in gerontology: mechanisms and applications for healthy agingReviewMavrych V, Shypilova I, Bolgova O · Front Aging, 2026 · PMID 42021992 · DOI
  8. A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical reviewReviewCoutinho LFD, DE Oliveira Neves LF, Camilo RP · J Sports Med Phys Fitness, 2026 · PMID 41880199 · DOI

I primi 8 di 50 risultati, per pertinenza. Vedi tutti su PubMed.

Kisspeptin-10

  1. Investigating the detection of the novel doping‐relevant peptide kisspeptin‐10 in urine using liquid chromatography high‐resolution mass spectrometryEnglish AbstractColpaert T, Risseeuw M, Deventer K et al. · Biomed Chromatogr, 2024 · PMID 38978171 · DOI
  2. Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of SrcResearch Support, Non-U.S. Gov'tLi Z, Yang X, Fu R et al. · Nat Commun, 2024 · PMID 38346942 · DOI
  3. Author Correction: Kisspeptin-10 binding to Gpr54 in osteoclasts prevents bone loss by activating Dusp18-mediated dephosphorylation of SrcPublished ErratumLi Z, Yang X, Fu R et al. · Nat Commun, 2024 · PMID 39702286 · DOI
  4. Kisspeptin-10 increases collagen content in the myocardium by focal adhesion kinase activityResearch Support, Non-U.S. Gov'tRadwańska P, Gałdyszyńska M, Piera L et al. · Sci Rep, 2023 · PMID 37968564 · DOI
  5. Kisspeptin-10 Ameliorates Obesity-Diabetes with Diverse Effects on Ileal Enteroendocrine Cells and Pancreatic Islet Morphology in High-Fat Fed Female MiceResearch Support, Non-U.S. Gov'tSridhar A, Khan D, Muthukumar R et al. · Biomolecules, 2025 · PMID 41301510 · DOI
  6. A kisspeptin-10 analog with greater in vivo bioactivity than kisspeptin-10Comparative StudyResearch Support, Non-U.S. Gov'tCurtis AE, Cooke JH, Baxter JE et al. · Am J Physiol Endocrinol Metab, 2010 · PMID 19934405 · DOI
  7. Kisspeptin-10 in cryodiluent improves the post-thaw quality of Nili-Ravi buffalo (Bubalus bubalis) bull spermatozoaFayyaz MH, Andrabi SMH, Haider MS et al. · Andrologia, 2022 · PMID 36054451 · DOI
  8. Kisspeptin-10 potentiates miniature excitatory postsynaptic currents in the rat supraoptic nucleusResearch Support, Non-U.S. Gov'tYokoyama T, Minami K, Terawaki K et al. · Brain Res, 2014 · PMID 25130664 · DOI

I primi 8 di 316 risultati, per pertinenza. Vedi tutti su PubMed.

KPV (Lys-Pro-Val)

  1. Transdermal Iontophoretic Delivery of Lysine-Proline-Valine (KPV) Peptide Across Microporated Human SkinResearch Support, U.S. Gov't, Non-P.H.S.Pawar K, Kolli CS, Rangari VK et al. · J Pharm Sci, 2017 · PMID 28343991 · DOI
  2. PepT1-mediated tripeptide KPV uptake reduces intestinal inflammationResearch Support, N.I.H., ExtramuralDalmasso G, Charrier-Hisamuddin L, Nguyen HT et al. · Gastroenterology, 2008 · PMID 18061177 · DOI
  3. A KPV-binding double-network hydrogel restores gut mucosal barrier in an inflamed colonResearch Support, Non-U.S. Gov'tZhao Y, Xue P, Lin G et al. · Acta Biomater, 2022 · PMID 35245681 · DOI
  4. Self-Cross-Linked Hydrogel of Cysteamine-Grafted γ-Polyglutamic Acid Stabilized Tripeptide KPV for Alleviating TNBS-Induced Ulcerative Colitis in RatsResearch Support, Non-U.S. Gov'tSun J, Xue P, Liu J et al. · ACS Biomater Sci Eng, 2021 · PMID 34547895 · DOI
  5. Melanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel diseaseComparative StudyResearch Support, Non-U.S. Gov'tKannengiesser K, Maaser C, Heidemann J et al. · Inflamm Bowel Dis, 2008 · PMID 18092346 · DOI
  6. Dissection of the anti-inflammatory effect of the core and C-terminal (KPV) alpha-melanocyte-stimulating hormone peptidesResearch Support, Non-U.S. Gov'tGetting SJ, Schiöth HB, Perretti M · J Pharmacol Exp Ther, 2003 · PMID 12750433 · DOI
  7. Orally Targeted Delivery of Tripeptide KPV via Hyaluronic Acid-Functionalized Nanoparticles Efficiently Alleviates Ulcerative ColitisXiao B, Xu Z, Viennois E et al. · Mol Ther, 2017 · PMID 28143741 · DOI
  8. Peptide Receptor-Targeted Fluorescent Probe: Visualization and Discrimination between Chronic and Acute Ulcerative ColitisZeng M, Shao A, Li H et al. · ACS Appl Mater Interfaces, 2017 · PMID 28349696 · DOI

I primi 8 di 84 risultati, per pertinenza. Vedi tutti su PubMed.

Liraglutide

  1. Liraglutide and Cardiovascular Outcomes in Type 2 DiabetesMulticenter StudyRandomized Controlled TrialResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tMarso SP, Daniels GH, Brown-Frandsen K et al. · N Engl J Med, 2016 · PMID 27295427 · DOI
  2. The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight lossResearch Support, Non-U.S. Gov'tSecher A, Jelsing J, Baquero AF et al. · J Clin Invest, 2014 · PMID 25202980 · DOI
  3. Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK/ACC signaling and inhibiting ferroptosisResearch Support, Non-U.S. Gov'tGuo T, Yan W, Cui X et al. · Mol Med, 2023 · PMID 37770820 · DOI
  4. Liraglutide Promotes Diabetic Wound Healing via Myo1c/Dock5Research Support, Non-U.S. Gov'tZhang Q, Zhang C, Kang C et al. · Adv Sci (Weinh), 2024 · PMID 39159301 · DOI
  5. Empagliflozin and liraglutide ameliorate HFpEF in mice via augmenting the Erbb4 signaling pathwayNi XY, Feng XJ, Wang ZH et al. · Acta Pharmacol Sin, 2024 · PMID 38589689 · DOI
  6. Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical TrialMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov'tDavies MJ, Bergenstal R, Bode B et al. · JAMA, 2015 · PMID 26284720 · DOI
  7. LiraglutideStudy GuideCerillo JL, Parmar M · 2024 · PMID 39383283
  8. Efficacy and Safety of Liraglutide Added to Insulin Treatment in Type 1 Diabetes: The ADJUNCT ONE Treat-To-Target Randomized TrialClinical Trial, Phase IIIMulticenter StudyRandomized Controlled TrialMathieu C, Zinman B, Hemmingsson JU et al. · Diabetes Care, 2016 · PMID 27506222 · DOI

I primi 8 di 5.656 risultati, per pertinenza. Vedi tutti su PubMed.

LL-37

  1. Vitamin D triggers hCAP18/LL-37 production: Implications for LL-37-induced human osteoblast cytotoxicityResearch Support, Non-U.S. Gov'tAidoukovitch A, Bankell E, Svensson D et al. · Biochem Biophys Res Commun, 2024 · PMID 38642493 · DOI
  2. Human antimicrobial/host defense peptide LL-37 may prevent the spread of a local infection through multiple mechanisms: an updateReviewSvensson D, Nilsson BO · Inflamm Res, 2025 · PMID 40063262 · DOI
  3. LL-37, a Multi-Faceted Amphipathic Peptide Involved in NETosisEditorialRadic M, Muller S · Cells, 2022 · PMID 35954305 · DOI
  4. LL-37: A Direct Link Between Inflammation and Myocardial InfarctionEditorialSchneider DJ · JACC Basic Transl Sci, 2024 · PMID 39170953 · DOI
  5. LL-37: Cathelicidin-related antimicrobial peptide with pleiotropic activityReviewFabisiak A, Murawska N, Fichna J · Pharmacol Rep, 2016 · PMID 27117377 · DOI
  6. LL-37 Triggers Antimicrobial Activity in Human PlateletsSánchez-Peña FJ, Romero-Tlalolini MLÁ, Torres-Aguilar H et al. · Int J Mol Sci, 2023 · PMID 36769137 · DOI
  7. Cathelicidin LL-37: a multitask antimicrobial peptideReviewBucki R, Leszczyńska K, Namiot A et al. · Arch Immunol Ther Exp (Warsz), 2010 · PMID 20049649 · DOI
  8. The LL-37 domain: A clue to cathelicidin immunomodulatory response?Research Support, Non-U.S. Gov'tReviewLeite ML, Duque HM, Rodrigues GR et al. · Peptides, 2023 · PMID 37068711 · DOI

I primi 8 di 2.538 risultati, per pertinenza. Vedi tutti su PubMed.

Mazdutide

  1. Once-Weekly Mazdutide in Chinese Adults with Obesity or OverweightRandomized Controlled TrialClinical Trial, Phase IIIMulticenter StudyJi L, Jiang H, Bi Y et al. · N Engl J Med, 2025 · PMID 40421736 · DOI
  2. Emerging pharmacotherapies for obesity: A systematic reviewSystematic ReviewKokkorakis M, Chakhtoura M, Rhayem C et al. · Pharmacol Rev, 2025 · PMID 39952695 · DOI
  3. Comparative effects of drugs for adults with overweight or obesity: systematic review and network meta-analysisSystematic ReviewNetwork Meta-AnalysisComparative StudyNong K, Shi Q, Xie X et al. · BMJ, 2026 · PMID 42419792 · DOI
  4. Mazdutide: First ApprovalReviewShirley M · Drugs, 2025 · PMID 41028652 · DOI
  5. Beyond weight loss: multisystem benefits of obesity medicationsReviewSavas M, Kuckuck S, Boon MR et al. · Lancet Diabetes Endocrinol, 2026 · PMID 42208956 · DOI
  6. Novel GLP-1-based Medications for Type 2 Diabetes and ObesityReviewSon JW, le Roux CW, Blüher M et al. · Endocr Rev, 2026 · PMID 41054801 · DOI
  7. Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trialsSystematic ReviewNetwork Meta-AnalysisResearch Support, Non-U.S. Gov'tXie Z, Zheng G, Liang Z et al. · Metabolism, 2024 · PMID 39305981 · DOI
  8. Efficacy and Safety of Mazdutide in Chinese Patients With Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Phase 2 TrialRandomized Controlled TrialClinical Trial, Phase IIResearch Support, Non-U.S. Gov'tZhang B, Cheng Z, Chen J et al. · Diabetes Care, 2024 · PMID 37943529 · DOI

I primi 8 di 51 risultati, per pertinenza. Vedi tutti su PubMed.

Melanotan II

  1. Melanotan-II reverses memory impairment induced by a short-term HF dietWekwejt P, Wojda U, Kiryk A · Biomed Pharmacother, 2023 · PMID 37478579 · DOI
  2. Melanotan II User Experience: A Qualitative Study of Online Discussion ForumsGilhooley E, Daly S, McKenna D · Dermatology, 2021 · PMID 34464955 · DOI
  3. CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR AgonistsResearch Support, Non-U.S. Gov'tTomassi S, Dimmito MP, Cai M et al. · J Med Chem, 2022 · PMID 35188390 · DOI
  4. Melanotan II: a possible cause of renal infarction: review of the literature and case reportCase ReportsReviewPeters B, Hadimeri H, Wahlberg R et al. · CEN Case Rep, 2020 · PMID 31953620 · DOI
  5. Melanotan II injection resulting in systemic toxicity and rhabdomyolysisCase ReportsNelson ME, Bryant SM, Aks SE · Clin Toxicol (Phila), 2012 · PMID 23121206 · DOI
  6. Melanoma associated with the use of melanotan-IIHjuler KF, Lorentzen HF · Dermatology, 2014 · PMID 24355990 · DOI
  7. Melanotan-II: Investigation of the inducer and facilitator effects on penile erection in anaesthetized ratGiuliano F, Clément P, Droupy S et al. · Neuroscience, 2006 · PMID 16360286 · DOI
  8. Melanotan-II reverses autistic features in a maternal immune activation mouse model of autismResearch Support, Non-U.S. Gov'tMinakova E, Lang J, Medel-Matus JS et al. · PLoS One, 2019 · PMID 30629642 · DOI

I primi 8 di 195 risultati, per pertinenza. Vedi tutti su PubMed.

MOTS-c

  1. MOTS-c: A promising mitochondrial-derived peptide for therapeutic exploitationReviewResearch Support, Non-U.S. Gov'tZheng Y, Wei Z, Wang T · Front Endocrinol (Lausanne), 2023 · PMID 36761202 · DOI
  2. The mitochondrial-derived peptide MOTS-c promotes metabolic homeostasis and reduces obesity and insulin resistanceResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tLee C, Zeng J, Drew BG et al. · Cell Metab, 2015 · PMID 25738459 · DOI
  3. Mitochondrial-Derived Peptide MOTS-c Suppresses Ovarian Cancer Progression by Attenuating USP7-Mediated LARS1 DeubiquitinationResearch Support, Non-U.S. Gov'tYin Y, Li Y, Ma B et al. · Adv Sci (Weinh), 2024 · PMID 39321430 · DOI
  4. MOTS-c is an exercise-induced mitochondrial-encoded regulator of age-dependent physical decline and muscle homeostasisResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tReynolds JC, Lai RW, Woodhead JST et al. · Nat Commun, 2021 · PMID 33473109 · DOI
  5. The mitochondrial-derived peptide MOTS-c relieves hyperglycemia and insulin resistance in gestational diabetes mellitusResearch Support, Non-U.S. Gov'tYin Y, Pan Y, He J et al. · Pharmacol Res, 2022 · PMID 34798268 · DOI
  6. MOTS-c attenuates lung ischemia-reperfusion injury via MYH9-Dependent nuclear translocation and transcriptional activation of antioxidant genesResearch Support, Non-U.S. Gov'tLi X, Zhan F, Qiu G et al. · Redox Biol, 2025 · PMID 40403491 · DOI
  7. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceReviewMendias CL, Awan TM · Sports Med, 2026 · PMID 41966639 · DOI
  8. Circulating levels of MOTS-c in patients with breast cancer treated with metforminRandomized Controlled TrialResearch Support, Non-U.S. Gov'tCuyàs E, Verdura S, Martin-Castillo B et al. · Aging (Albany NY), 2022 · PMID 36490309 · DOI

I primi 8 di 257 risultati, per pertinenza. Vedi tutti su PubMed.

NAD+

  1. Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many UnknownsReviewBhasin S, Seals D, Migaud M et al. · Endocr Rev, 2023 · PMID 37364580 · DOI
  2. Placental nicotinamide adenine dinucleotide modulates the timing of laborCiampa EJ, Machado LM, Lee KJ et al. · Science, 2026 · PMID 42275500 · DOI
  3. Editorial: The Versatile Role of Nicotinamide Adenine Dinucleotide in ImmunityEditorialIntroductory Journal ArticleResearch Support, Non-U.S. Gov'tRissiek B, Guse AH, Adriouch S et al. · Front Immunol, 2021 · PMID 34912350 · DOI
  4. Nicotinamide adenine dinucleotide metabolism: driving or counterbalancing inflammatory bowel disease?ReviewResearch Support, Non-U.S. Gov'tXue X, Miao Y, Wei Z · FEBS Lett, 2023 · PMID 36310388 · DOI
  5. Nicotinamide adenine dinucleotide and the sirtuins caution: Pro-cancer functionsReviewPalmer RD, Vaccarezza M · Aging Med (Milton), 2021 · PMID 34964015 · DOI
  6. Nicotinamide Adenine Dinucleotide Supplementation to Alleviate Heart Failure: A Mitochondrial Dysfunction PerspectiveReviewYu F, Zhao H, Luo L et al. · Nutrients, 2025 · PMID 40507126 · DOI
  7. Nicotinamide Adenine Dinucleotide (NAD(+))-Dependent Signaling in Neurological DisordersReviewResearch Support, N.I.H., ExtramuralBresque M, Esteve D, Pehar M et al. · Antioxid Redox Signal, 2023 · PMID 37288742 · DOI
  8. A Prebiotic Pathway to Nicotinamide Adenine DinucleotideBechtel M, Kurrle NJ, Trapp O · Chemistry, 2024 · PMID 38884181 · DOI

I primi 8 di 2.187 risultati, per pertinenza. Vedi tutti su PubMed.

Oxytocin

  1. The physiology and pharmacology of oxytocin in labor and in the peripartum periodReviewUvnäs-Moberg K · Am J Obstet Gynecol, 2024 · PMID 38462255 · DOI
  2. Is Oxytocin "Nature's Medicine"?Research Support, N.I.H., ExtramuralReviewCarter CS, Kenkel WM, MacLean EL et al. · Pharmacol Rev, 2020 · PMID 32912963 · DOI
  3. Oxytocin signaling regulates maternally directed behavior during early lifeResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tZelmanoff DD, Bornstein R, Kaufman M et al. · Science, 2025 · PMID 40934325 · DOI
  4. Maternal plasma levels of oxytocin during breastfeeding-A systematic reviewResearch Support, Non-U.S. Gov'tSystematic ReviewUvnäs Moberg K, Ekström-Bergström A, Buckley S et al. · PLoS One, 2020 · PMID 32756565 · DOI
  5. Neural circuitry for maternal oxytocin release induced by infant criesResearch Support, U.S. Gov't, Non-P.H.S.Research Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tValtcheva S, Issa HA, Bair-Marshall CJ et al. · Nature, 2023 · PMID 37730989 · DOI
  6. Oxytocin and appetiteResearch Support, Non-U.S. Gov'tReviewLeng G, Onaka T, Caquineau C et al. · Prog Brain Res, 2008 · PMID 18655879 · DOI
  7. Chronic oxytocin administration stimulates the oxytocinergic system in children with autismRandomized Controlled TrialResearch Support, Non-U.S. Gov'tMoerkerke M, Daniels N, Tibermont L et al. · Nat Commun, 2024 · PMID 38167302 · DOI
  8. Close encounters with oxytocinReviewCarter CS · Compr Psychoneuroendocrinol, 2023 · PMID 37577297 · DOI

I primi 8 di 29.361 risultati, per pertinenza. Vedi tutti su PubMed.

Palmitoyl pentapeptide-4

  1. Topical palmitoyl pentapeptide provides improvement in photoaged human facial skinRobinson LR, Fitzgerald NC, Doughty DG et al. · Int J Cosmet Sci, 2005 · PMID 18492182 · DOI
  2. Bioactive Glycyrrhizic Acid Ionic Liquid Self-Assembled Nanomicelles for Enhanced Transdermal Delivery of Anti-Photoaging Signal PeptidesWang Z, Liu J, Chen Q et al. · Adv Sci (Weinh), 2025 · PMID 39783908 · DOI
  3. Dermal Stability and In Vitro Skin Permeation of Collagen Pentapeptides (KTTKS and palmitoyl-KTTKS)Choi YL, Park EJ, Kim E et al. · Biomol Ther (Seoul), 2014 · PMID 25143811 · DOI
  4. The Effects of a Novel Series of KTTKS Analogues on Cytotoxicity and Proteolytic ActivityTałałaj U, Uścinowicz P, Bruzgo I et al. · Molecules, 2019 · PMID 31618846 · DOI
  5. Liposome Encapsulation of the Palmitoyl-KTTKS Peptide: Structural and Functional CharacterizationVitali A, Paolicelli P, Bigi B et al. · Pharmaceutics, 2024 · PMID 38399273 · DOI
  6. Mesenchymal stem cell therapy using Pal-KTTKS-enriched carboxylated cellulose improves burn wound in rat modelRasouli M, Shahghasempour L, Shirbaghaee Z et al. · Arch Dermatol Res, 2024 · PMID 38850353 · DOI
  7. Effect of Palmitic Acid Conjugation on Physicochemical Properties of Peptide KTTKS: A Preformulation StudyMortazavi SM, Kobarfard F, Maibach HI et al. · J Cosmet Sci, 2019 · PMID 31829923
  8. Practical application of cellular bioenergetics to the care of aged skinResearch Support, Non-U.S. Gov'tOsborne R, Carver RS, Mullins LA et al. · Br J Dermatol, 2013 · PMID 23786618 · DOI

I primi 8 di 20 risultati, per pertinenza. Vedi tutti su PubMed.

Retatrutide

  1. Efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 trialRandomized Controlled TrialClinical Trial, Phase IIIMulticenter StudyResearch Support, Non-U.S. Gov'tBajaj HS, Welch M, Shah P et al. · Lancet, 2026 · PMID 42250575 · DOI
  2. Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes : A Systematic Review of Randomized Controlled TrialsSystematic ReviewMoiz A, Filion KB, Toutounchi H et al. · Ann Intern Med, 2025 · PMID 39761578 · DOI
  3. Novel GLP-1-based Medications for Type 2 Diabetes and ObesityReviewSon JW, le Roux CW, Blüher M et al. · Endocr Rev, 2026 · PMID 41054801 · DOI
  4. Triple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 TrialRandomized Controlled TrialClinical Trial, Phase IIJastreboff AM, Kaplan LM, Frías JP et al. · N Engl J Med, 2023 · PMID 37366315 · DOI
  5. Retatrutide-A Game Changer in Obesity PharmacotherapyReviewKatsi V, Koutsopoulos G, Fragoulis C et al. · Biomolecules, 2025 · PMID 40563436 · DOI
  6. Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and ObesityReviewResearch Support, Non-U.S. Gov'tDrucker DJ · Diabetes Care, 2024 · PMID 38843460 · DOI
  7. Comparison of the effects of Liraglutide, Tirzepatide, and Retatrutide on diabetic kidney disease in db/db miceComparative StudyMa J, Hu X, Zhang W et al. · Endocrine, 2025 · PMID 39212900 · DOI
  8. Comparative efficacy of incretin drugs on glycemic control, body weight, and blood pressure in adults with overweight or obesity and with/without type 2 diabetes: a systematic review and network meta-analysisComparative StudyNetwork Meta-AnalysisSystematic ReviewLiu S, Hu J, Zhao C et al. · Front Endocrinol (Lausanne), 2025 · PMID 39968298 · DOI

I primi 8 di 193 risultati, per pertinenza. Vedi tutti su PubMed.

Selank

  1. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsReviewRahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev, 2026 · PMID 41490200 · DOI
  2. Functional Connectomic Approach to Studying Selank and Semax EffectsPanikratova YR, Lebedeva IS, Sokolov OY et al. · Dokl Biol Sci, 2020 · PMID 32342318 · DOI
  3. [Effects of heptapeptide selank on genetically-based and situation-provoked symptoms of depression in behavior in WAG/Rij and Wistar rats, and in BALB/c mice]Research Support, Non-U.S. Gov'tSarkisova KIu, Kozlovskiĭ II, Kozlovskaia MM · Zh Vyssh Nerv Deiat Im I P Pavlova, 2008 · PMID 18661785
  4. GABA, Selank, and Olanzapine Affect the Expression of Genes Involved in GABAergic Neurotransmission in IMR-32 CellsFilatova E, Kasian A, Kolomin T et al. · Front Pharmacol, 2017 · PMID 28293190 · DOI
  5. The optimizing action of the synthetic peptide Selank on a conditioned active avoidance reflex in ratsComparative StudyResearch Support, Non-U.S. Gov'tKozlovskii II, Danchev ND · Neurosci Behav Physiol, 2003 · PMID 14552529 · DOI
  6. Peptide Selank Enhances the Effect of Diazepam in Reducing Anxiety in Unpredictable Chronic Mild Stress Conditions in RatsKasian A, Kolomin T, Andreeva L et al. · Behav Neurol, 2017 · PMID 28280289 · DOI
  7. Selank Administration Affects the Expression of Some Genes Involved in GABAergic NeurotransmissionVolkova A, Shadrina M, Kolomin T et al. · Front Pharmacol, 2016 · PMID 26924987 · DOI
  8. The temporary dynamics of inflammation-related genes expression under tuftsin analog Selank actionResearch Support, Non-U.S. Gov'tKolomin T, Morozova M, Volkova A et al. · Mol Immunol, 2014 · PMID 24291245 · DOI

I primi 8 di 68 risultati, per pertinenza. Vedi tutti su PubMed.

Semaglutide

  1. Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trialClinical Trial, Phase IIIRandomized Controlled TrialResearch Support, Non-U.S. Gov'tEquivalence TrialKadowaki T, Isendahl J, Khalid U et al. · Lancet Diabetes Endocrinol, 2022 · PMID 35131037 · DOI
  2. Safety of SemaglutideResearch Support, Non-U.S. Gov'tReviewSmits MM, Van Raalte DH · Front Endocrinol (Lausanne), 2021 · PMID 34305810 · DOI
  3. Efficacy and Safety of Semaglutide for Weight Loss in Obesity Without Diabetes: A Systematic Review and Meta-AnalysisMeta-AnalysisSystematic ReviewTan HC, Dampil OA, Marquez MM · J ASEAN Fed Endocr Soc, 2022 · PMID 36578889 · DOI
  4. A systematic review of the effect of semaglutide on lean mass: insights from clinical trialsSystematic ReviewBikou A, Dermiki-Gkana F, Penteris M et al. · Expert Opin Pharmacother, 2024 · PMID 38629387 · DOI
  5. Semaglutide lowers body weight in rodents via distributed neural pathwaysResearch Support, Non-U.S. Gov'tGabery S, Salinas CG, Paulsen SJ et al. · JCI Insight, 2020 · PMID 32213703 · DOI
  6. Wegovy (semaglutide): a new weight loss drug for chronic weight managementReviewSingh G, Krauthamer M, Bjalme-Evans M · J Investig Med, 2022 · PMID 34706925 · DOI
  7. Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection FractionComparative StudyObservational StudyKrüger N, Schneeweiss S, Fuse K et al. · JAMA, 2025 · PMID 40886075 · DOI
  8. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trialRandomized Controlled TrialMulticenter StudyResearch Support, Non-U.S. Gov'tRyan DH, Lingvay I, Deanfield J et al. · Nat Med, 2024 · PMID 38740993 · DOI

I primi 8 di 5.624 risultati, per pertinenza. Vedi tutti su PubMed.

Semax

  1. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsReviewRahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev, 2026 · PMID 41490200 · DOI
  2. Functional Connectomic Approach to Studying Selank and Semax EffectsPanikratova YR, Lebedeva IS, Sokolov OY et al. · Dokl Biol Sci, 2020 · PMID 32342318 · DOI
  3. Therapeutic peptides in gerontology: mechanisms and applications for healthy agingReviewMavrych V, Shypilova I, Bolgova O · Front Aging, 2026 · PMID 42021992 · DOI
  4. Gateways to clinical trialsBibliographyBayes M, Rabasseda X, Prous JR · Methods Find Exp Clin Pharmacol, 2005 · PMID 16082427
  5. Semax, an ACTH(4-10) analogue with nootropic properties, activates dopaminergic and serotoninergic brain systems in rodentsResearch Support, Non-U.S. Gov'tEremin KO, Kudrin VS, Saransaari P et al. · Neurochem Res, 2005 · PMID 16362768 · DOI
  6. Effects of Semax on the Default Mode Network of the BrainLebedeva IS, Panikratova YR, Sokolov OY et al. · Bull Exp Biol Med, 2018 · PMID 30225715 · DOI
  7. Pharmacological Aspects of Neuro-Immune InteractionsResearch Support, Non-U.S. Gov'tReviewTarasov VV, Kudryashov NV, Chubarev VN et al. · Curr Pharm Des, 2018 · PMID 28875850 · DOI
  8. Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female miceLiu R, Chen Y, Huang H et al. · Br J Pharmacol, 2025 · PMID 40692165 · DOI

I primi 8 di 208 risultati, per pertinenza. Vedi tutti su PubMed.

Sermorelin

  1. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsReviewRahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev, 2026 · PMID 41490200 · DOI
  2. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceReviewMendias CL, Awan TM · Sports Med, 2026 · PMID 41966639 · DOI
  3. Advances in the detection of growth hormone releasing hormone synthetic analogsValidation StudyMemdouh S, Gavrilović I, Ng K et al. · Drug Test Anal, 2021 · PMID 34665524 · DOI
  4. A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical reviewReviewCoutinho LFD, DE Oliveira Neves LF, Camilo RP · J Sports Med Phys Fitness, 2026 · PMID 41880199 · DOI
  5. Beyond the androgen receptor: the role of growth hormone secretagogues in the modern management of body composition in hypogonadal malesReviewSinha DK, Balasubramanian A, Tatem AJ et al. · Transl Androl Urol, 2020 · PMID 32257855 · DOI
  6. In-house standards derived from doping peptides: Enzymatic and serum stability and degradation profile of GHRP and GHRH-related peptidesGonzález-López NM, Guerra-Acero-Turizo LM, Blanco-Medina I et al. · Biomed Chromatogr, 2023 · PMID 37688464 · DOI
  7. Cationic exchange SPE combined with triple quadrupole UHPLC-MS/MS for detection of GHRHs in urine samplesResearch Support, Non-U.S. Gov'tCristea CD, Radu M, Toboc A et al. · Anal Biochem, 2023 · PMID 37806509 · DOI
  8. A potentially effective drug for patients with recurrent glioma: sermorelinChang Y, Huang R, Zhai Y et al. · Ann Transl Med, 2021 · PMID 33842627 · DOI

I primi 8 di 24 risultati, per pertinenza. Vedi tutti su PubMed.

Survodutide

  1. Efficacy and Safety of GLP-1 Receptor Agonists, Dual Agonists, and Retatrutide for Weight Loss in Adults With Overweight or Obesity: A Bayesian NMANetwork Meta-AnalysisSystematic ReviewSinha B, Ghosal S · Obesity (Silver Spring), 2025 · PMID 40685589 · DOI
  2. Efficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and ObesityReviewResearch Support, Non-U.S. Gov'tDrucker DJ · Diabetes Care, 2024 · PMID 38843460 · DOI
  3. GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitisReviewSingh A, Sohal A, Batta A · World J Gastroenterol, 2024 · PMID 39735270 · DOI
  4. A Phase 2 Randomized Trial of Survodutide in MASH and FibrosisClinical Trial, Phase IIRandomized Controlled TrialMulticenter StudySanyal AJ, Bedossa P, Fraessdorf M et al. · N Engl J Med, 2024 · PMID 38847460 · DOI
  5. Emerging pharmacotherapies for obesity: A systematic reviewSystematic ReviewKokkorakis M, Chakhtoura M, Rhayem C et al. · Pharmacol Rev, 2025 · PMID 39952695 · DOI
  6. Therapeutic horizons in metabolic dysfunction-associated steatohepatitisReviewResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tNewsome PN, Loomba R · J Clin Invest, 2025 · PMID 40590228 · DOI
  7. Weight management treatment in obesityReviewRubio-Herrera MA, Mera-Carreiro S · Med Clin (Barc), 2025 · PMID 40865172 · DOI
  8. Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trialClinical Trial, Phase IIMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov'tle Roux CW, Steen O, Lucas KJ et al. · Lancet Diabetes Endocrinol, 2024 · PMID 38330987 · DOI

I primi 8 di 85 risultati, per pertinenza. Vedi tutti su PubMed.

Tesamorelin

  1. Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine PhysiciansReviewMayfield CK, Bolia IK, Feingold CL et al. · Am J Sports Med, 2026 · PMID 41476424 · DOI
  2. Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future DirectionsReviewRahman OF, Lee SJ, Seeds WA · J Am Acad Orthop Surg Glob Res Rev, 2026 · PMID 41490200 · DOI
  3. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceReviewMendias CL, Awan TM · Sports Med, 2026 · PMID 41966639 · DOI
  4. TesamorelinReview2012 · PMID 31644039
  5. TesamorelinNewsGrunfeld C, Dritselis A, Kirkpatrick P · Nat Rev Drug Discov, 2011 · PMID 21283099 · DOI
  6. Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future PerspectivesReviewRenke G, Chinellato L · Int J Mol Sci, 2026 · PMID 42123471 · DOI
  7. Therapeutic augmentation of the growth hormone axis to improve outcomes following peripheral nerve injuryReviewTuffaha SH, Singh P, Budihardjo JD et al. · Expert Opin Ther Targets, 2016 · PMID 27192539 · DOI
  8. Tesamorelin updateNewspaper ArticleO'Neal R · BETA, 2010 · PMID 21591600

I primi 8 di 94 risultati, per pertinenza. Vedi tutti su PubMed.

Thymosin alpha-1

  1. Thymosin alpha-1ReviewAncell CD, Phipps J, Young L · Am J Health Syst Pharm, 2001 · PMID 11381492 · DOI
  2. Thymosin alpha-1 treatment in chronic hepatitis BEditorialResearch Support, Non-U.S. Gov'tWu X, Jia J, You H · Expert Opin Biol Ther, 2015 · PMID 25640173 · DOI
  3. Aging and Thymosin Alpha-1ReviewSimonova MA, Ivanov I, Shoshina NS et al. · Int J Mol Sci, 2025 · PMID 41373628 · DOI
  4. Thymosin alpha 1 treatment for patients with sepsisResearch Support, Non-U.S. Gov'tReviewPei F, Guan X, Wu J · Expert Opin Biol Ther, 2018 · PMID 30063866 · DOI
  5. Thymosin α1 reverses oncolytic adenovirus-induced M2 polarization of macrophages to improve antitumor immunity and therapeutic efficacyResearch Support, Non-U.S. Gov'tLiu K, Kong L, Cui H et al. · Cell Rep Med, 2024 · PMID 39357524 · DOI
  6. Immune Modulation with Thymosin Alpha 1 TreatmentReviewKing R, Tuthill C · Vitam Horm, 2016 · PMID 27450734 · DOI
  7. Serum thymosin alpha 1 levels in normal and pathological conditionsReviewPica F, Gaziano R, Casalinuovo IA et al. · Expert Opin Biol Ther, 2018 · PMID 30063864 · DOI
  8. Clinical applications of thymosin alpha-1EditorialReviewCommentGoldstein AL · Cancer Invest, 1994 · PMID 7922712 · DOI

I primi 8 di 622 risultati, per pertinenza. Vedi tutti su PubMed.

Thymosin beta-4

  1. Thymosin beta 4 as an Alzheimer disease intervention target identified using human brain organoidsResearch Support, Non-U.S. Gov'tZeng PM, Sun XY, Li Y et al. · Stem Cell Reports, 2025 · PMID 40816274 · DOI
  2. Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic PerformanceReviewMendias CL, Awan TM · Sports Med, 2026 · PMID 41966639 · DOI
  3. beta-ThymosinsResearch Support, Non-U.S. Gov'tReviewHannappel E · Ann N Y Acad Sci, 2007 · PMID 17468232 · DOI
  4. Recombinant human thymosin beta 4 improves ischemic cardiac dysfunction in mice and patients with acute ST-segment elevation myocardial infarction after reperfusionResearch Support, Non-U.S. Gov'tZhang Y, Dong Q, Bian X et al. · Cardiovasc Res, 2025 · PMID 41229390 · DOI
  5. Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applicationsGoldstein AL, Hannappel E, Sosne G et al. · Expert Opin Biol Ther, 2012 · PMID 22074294 · DOI
  6. Thymosin beta 4 interactionsResearch Support, U.S. Gov't, Non-P.H.S.ReviewBubb MR · Vitam Horm, 2003 · PMID 12852258 · DOI
  7. The beta-thymosin enigmaResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tReviewSun HQ, Yin HL · Ann N Y Acad Sci, 2007 · PMID 17495248 · DOI
  8. Cardioprotection by Thymosin Beta 4ReviewPipes GT, Yang J · Vitam Horm, 2016 · PMID 27450736 · DOI

I primi 8 di 602 risultati, per pertinenza. Vedi tutti su PubMed.

Tirzepatide

  1. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity: The SURMOUNT-4 Randomized Clinical TrialClinical Trial, Phase IIIMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov'tAronne LJ, Sattar N, Horn DB et al. · JAMA, 2024 · PMID 38078870 · DOI
  2. Subcutaneously administered tirzepatide vs semaglutide for adults with type 2 diabetes: a systematic review and network meta-analysis of randomised controlled trialsSystematic ReviewNetwork Meta-AnalysisKaragiannis T, Malandris K, Avgerinos I et al. · Diabetologia, 2024 · PMID 38613667 · DOI
  3. Semaglutide and Tirzepatide in Patients With Heart Failure With Preserved Ejection FractionComparative StudyObservational StudyKrüger N, Schneeweiss S, Fuse K et al. · JAMA, 2025 · PMID 40886075 · DOI
  4. Tirzepatide: A Review in Type 2 DiabetesReviewFrance NL, Syed YY · Drugs, 2024 · PMID 38388874 · DOI
  5. Tirzepatide as Compared with Semaglutide for the Treatment of ObesityClinical Trial, Phase IIIComparative StudyEquivalence TrialMulticenter StudyAronne LJ, Horn DB, le Roux CW et al. · N Engl J Med, 2025 · PMID 40353578 · DOI
  6. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 DiabetesClinical Trial, Phase IIIComparative StudyEquivalence TrialMulticenter StudyRandomized Controlled TrialResearch Support, Non-U.S. Gov'tFrías JP, Davies MJ, Rosenstock J et al. · N Engl J Med, 2021 · PMID 34170647 · DOI
  7. Tirzepatide for overweight and obesity managementReviewHamza M, Papamargaritis D, Davies MJ · Expert Opin Pharmacother, 2025 · PMID 39632534 · DOI
  8. Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trialClinical Trial, Phase IIIRandomized Controlled TrialRosenstock J, Wysham C, Frías JP et al. · Lancet, 2021 · PMID 34186022 · DOI

I primi 8 di 2.584 risultati, per pertinenza. Vedi tutti su PubMed.

Vasoactive intestinal peptide

  1. Vasoactive intestinal peptideResearch Support, U.S. Gov't, Non-P.H.S.Research Support, U.S. Gov't, P.H.S.ReviewSaid SI · J Endocrinol Invest, 1986 · PMID 2872248 · DOI
  2. Vasoactive Intestinal Peptide-Secreting Tumors: A ReviewReviewSiddappa PK, Vege SS · Pancreas, 2019 · PMID 31609932 · DOI
  3. Vasoactive intestinal peptide secreting tumour: An overviewReviewUna Cidon E · World J Gastrointest Oncol, 2022 · PMID 35582098 · DOI
  4. Role of vasoactive intestinal peptide in osteoarthritisReviewJiang W, Wang H, Li YS et al. · J Biomed Sci, 2016 · PMID 27553659 · DOI
  5. The role of vasoactive intestinal peptide in pulmonary diseasesReviewZhong HL, Li PZ, Li D et al. · Life Sci, 2023 · PMID 37742737 · DOI
  6. Vasoactive intestinal peptide in the heartResearch Support, Non-U.S. Gov'tReviewForssmann WG, Triepel J, Daffner C et al. · Ann N Y Acad Sci, 1988 · PMID 3291696 · DOI
  7. A Role for Vasoactive Intestinal Peptide Interneurons in Neurodevelopmental DisordersResearch Support, N.I.H., ExtramuralResearch Support, Non-U.S. Gov'tReviewGoff KM, Goldberg EM · Dev Neurosci, 2021 · PMID 33794534 · DOI
  8. Therapeutic potential of vasoactive intestinal peptide and its receptor VPAC2 in type 2 diabetesReviewResearch Support, Non-U.S. Gov'tHou X, Yang D, Yang G et al. · Front Endocrinol (Lausanne), 2022 · PMID 36204104 · DOI

I primi 8 di 8.397 risultati, per pertinenza. Vedi tutti su PubMed.

Il compendio

Tutti i peptidi

Tutte le voci, raggruppate per campo di ricerca. Ciascuna apre la propria scheda con i dati di identità, una frase di presentazione e la ricerca pubblicata.

Vedi come tabella dati →